Project Grant R56DK147805
Award Date 7/1/26
Completion Date 6/30/27
Dollars Obligated $302K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98101, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Benaroya Research Institute at Virginia Mason a $2.68 million Project Grant (CFDA 93.855, Allergy and Infectious Diseases Research) effective February 20, 2026, with a completion date of January 31, 2030. The award funds a longitudinal research study examining epitope-specific CD4+ T cell responses in individuals at risk for Type 1 Diabetes (T1D) before disease onset. The research aims to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Benaroya Research Institute At Virginia Mason a $894,183 Project Grant (CFDA 93.855: Allergy and Infectious Diseases Research) on June 11, 2026, to support research exploring in vivo regulatory T cell (Treg) function in Type 1 Diabetes (T1D). The research leverages existing primary human samples from the Sanford T-REX clinical trial to investigate how the proliferative capacity and metabolic...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,390,830 Project Grant to the University of California, San Francisco (UCSF) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 1, 2025, through August 31, 2029. This award funds the development of scalable and transplantable pancreatic islet organoids with engineered oxygenation to improve therapeutic...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Scripps Research Institute a $801,662 Project Grant effective August 15, 2025, through June 30, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project investigates the initiation of anti-islet autoimmunity in Type 1 Diabetes (T1D), a CD4 T cell-mediated autoimmune disease, with particular focus on understanding the role...
- Federal Project Grant Award Summary Versiti Blood Health, Inc. received a $127,500 Project Grant award, effective February 5, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The project, titled "Role of Force-Directed Lipid Metabolism in the Endothelial-to-Hematopoietic Transition," is scheduled for completion by December 31, 2027, and will be...
- Federal Project Grant Summary Cornell University received a $509,265 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 25, 2025, with completion scheduled for July 31, 2029. The award funds development of an immunomodulatory and vascularized cell delivery device designed to enable safe, long-term insulin-producing islet cell...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $178,000 to the Beckman Research Institute of the City of Hope under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a two-year project period (May 1, 2026–April 30, 2028). The research project, titled "Three-Dimensional Spatial and Translational Profiling of Stress Response Pathways in Type 1 Diabetes," investigates the...
- Summary of Federal Project Grant Award Icahn School of Medicine at Mount Sinai received a $253,500 Project Grant award dated August 21, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "Longitudinal Single Cell Responses in Human Islet Organoids to Beta Cell Regenerative Drugs," will be conducted through June 30, 2027, and...
- Federal Grant Award Summary Seattle Children's Research Institute received a $724,950 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded May 15, 2026, with completion scheduled for March 31, 2030. The project delivers fundamental research services focused on understanding heterochromatin-based gene silencing mechanisms, specifically the role of...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) was awarded $3,140,632 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a four-year project period from September 1, 2025, through August 31, 2029. This Project Grant supports fundamental biomedical research focused on elucidating the mechanisms of human endocrine lineage commitment...